清金化痰益肺汤联合常规西药治疗支气管肺炎临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R563.1

基金项目:


Clinical Study on Qingjin Huatan Yifei Decoction Combined with Routine Western Medicine for Bronchopneumonia
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察清金化痰益肺汤联合常规西药治疗支气管肺炎的临床疗效。方法:选择支气管肺炎患 儿88例,按随机数字表法分为对照组和观察组各44例。对照组给予常规西药治疗,观察组在对照组基础联合 清金化痰益肺汤治疗。评价2组临床疗效,比较2组治疗前后中医证候评分、肺功能指标、免疫功能指标及血 清炎症因子水平,统计2 组不良反应发生率。结果:观察组总有效率为95.45%,高于对照组79.55% (P< 0.05)。治疗后,2组主症评分、次症评分及总积分较治疗前降低(P<0.05),且观察组主症评分、次症评分及 总积分均低于对照组(P<0.05)。治疗后,2组用力肺活量(FVC)、第1秒用力呼气容积(FEV1)、第1秒用力 呼气容积占用力肺活量百分比(FEV1/FVC) 较治疗前升高(P<0.05),且观察组FVC、FEV1、FEV1/FVC高于 对照组(P<0.05)。治疗后,2组免疫球蛋白A(IgA)、免疫球蛋白G(IgG)、免疫球蛋白M(IgM) 水平较治 疗前升高(P<0.05),且观察组IgA、IgM、IgG 水平高于对照组(P<0.05)。治疗后, 2组血清肿瘤坏死 因子-α(TNF-α)、白细胞介素-8(IL-8)、C-反应蛋白(CRP) 水平较治疗前降低,干扰素-γ(IFN-γ) 水平 较治疗前升高(P<0.05);且观察组血清TNF-α、IL-8、CRP水平低于对照组,IFN-γ水平高于对照组(P< 0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:清金化痰益肺汤联合常规西药治疗支 气管肺炎可有效改善患者临床症状,改善呼吸功能并提高免疫功能,减轻气道炎症反应,降低不良反应发生率。

    Abstract:

    Abstract: Objective: To observe the clinical effect of Qingjin Huatan Yifei Decoction combined with routine western medicine for bronchopneumonia. Methods: A total of 88 cases of children with bronchopneumonia were selected and divided into the control group and the observation group according to the random number table method,with 44 cases in each group. The control group was treated with routine western medicine,and the observation group was additionally treated with Qingjin Huatan Yifei Decoction based on the treatment of the control group. The clinical effects in the two groups were evaluated; traditional Chinese medicine syndrome scores, lung function indexes, immune function indexes and serum inflammatory factor levels were compared before and after treatment between the two groups;the incidence rate of adverse reactions was analyzed. Results: The total effective rate was 95.45% in the observation group,higher than that of 79.55% in the control group (P<0.05). After treatment,the scores of main and secondary symptoms and the total scores in the two groups were decreased when compared with those before treatment (P<0.05), and the scores of main and secondary symptoms and the total scores in the observation group were lower than those in the control group (P<0.05). After treatment, forced vital capacity (FVC),forced expiratory volume in the first second (FEV1) and the percentage of forced expiratory volume in the first second to forced vital capacity (FEV1/FVC) in the two groups were increased when compared with those before treatment (P<0.05), and FVC, FEV1 and FEV1/FVC in the observation group were higher than those in the control group (P<0.05). After treatment,the levels of immunoglobulin A (IgA), immunoglobulin G (IgG) and immunoglobulin M (IgM) in the two groups were increased when compared with those before treatment (P<0.05), and the levels of IgA, IgM and IgG in the observation group were higher than those in the control group (P<0.05). After treatment,the levels of tumor necrosis factor- α (TNF- α), interleukin-8 (IL-8) and C-reactive protein (CRP) in serum in the two groups were decreased when compared with those before treatment, and the levels of interferon- γ (IFN- γ) were increased when compared with those before treatment (P<0.05);the levels of TNF- α,IL-8 and CRP in the observation group were lower than those in the control group,and the level of IFN- γ was higher than that in the control group (P<0.05). There was no significant difference being found in the comparison of the incidence of adverse reactions between the two groups (P>0.05). Conclusion: Qingjin Huatan Yifei Decoction combined with routine western medicine for bronchopneumonia can effectively improve the clinical symptoms, improve respiratory function and immune function, alleviate airway inflammation and reduce the incidence of adverse reactions.

    参考文献
    相似文献
    引证文献
引用本文

孟伟峰,何月敏.清金化痰益肺汤联合常规西药治疗支气管肺炎临床研究[J].新中医,2024,56(13):92-96

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2024-07-10
  • 出版日期:
文章二维码